Loading…
Greater Access to Affordable Pharmaceuticals Act
Legislative Progress
Momentum (last 30 days)
0
score
0 actions · 0 new cosponsors · 0 votes
Speed vs cohort
71pct
1d open
vs 3,018 other S bills in the 108th — cohort avg 48d
No CRS summary is available for this bill yet. The source title, actions, sponsors, and text versions below come from Congress.gov.
These links require the bill number to appear in the filing's source-reported specific issue text. Client expenses and lobbying-firm income are separate disclosure fields.
Filing registrants (1)
S1225 Greater Access to Affordable Pharmaceuticals Act
Client expense: $1,640,102 · Firm income: Not reported
Bills with similar content found using semantic analysis.
Sources: Congress.gov
Government targets: HOUSE OF REPRESENTATIVES, SENATE
S1225 Greater Access to Affordable Pharmaceuticals Act
Client expense: $1,958,138 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
S.1225, Greater Access to Affordable Pharmaceuticals Act
Client expense: $1,479,577 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
S.1225, Greater Access to Affordable Pharmaceuticals Act
Client expense: $1,479,577 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
S1225 Greater Access to Affordable Pharmaceuticals Act
Client expense: $1,474,129 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
S.1225, Greater Access to Affordable Pharmaceuticals Act
Client expense: $1,479,577 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
S.1225, Greater Access to Affordable Pharmaceuticals Act
Client expense: $1,479,577 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
| Democratic |
| GA |